Pitfalls in estimating piperaquine elimination.

Pitfalls in estimating piperaquine elimination.

By using a sensitive new assay, the terminal elimination half-life of the antimalarial piperaquine in a healthy volunteer was estimated to be 33 days, which is longer than estimated previously. This result illustrates the importance of extended sampling duration and sensitive assay methodologies in...

Descripció completa

Dades bibliogràfiques
Autors principals:	Tarning, J, Lindegårdh, N, Annerberg, A, Singtoroj, T, Day, N, Ashton, M, White, N
Format:	Journal article
Idioma:	English
Publicat:	2005

Ítems similars

Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
per: Tarning, J, et al.
Publicat: (2006)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
per: Tarning, J, et al.
Publicat: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
per: Tarning, J, et al.
Publicat: (2008)

Characterization of human urinary metabolites of the antimalarial piperaquine.
per: Tarning, J, et al.
Publicat: (2006)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
per: Tarning, J, et al.
Publicat: (2014)

A new approach to evaluate regression models during validation of bioanalytical assays.
per: Singtoroj, T, et al.
Publicat: (2006)

A new approach to evaluate regression models during validation of bioanalytical assays
per: Singtoroj, T, et al.
Publicat: (2006)

Quantification of the antimalarial piperaquine in plasma.
per: Tarning, J, et al.
Publicat: (2008)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
per: Annerberg, A, et al.
Publicat: (2011)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
per: Annerberg, A, et al.
Publicat: (2011)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
per: Tarning, J, et al.
Publicat: (2007)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
per: Tarning, J, et al.
Publicat: (2008)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.
per: Lindegardh, N, et al.
Publicat: (2008)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
per: Ashley, E, et al.
Publicat: (2010)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
per: Ashley, E, et al.
Publicat: (2010)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
per: Hoglund, R, et al.
Publicat: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
per: Tarning, J, et al.
Publicat: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
per: Tarning, J, et al.
Publicat: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
per: Tarning, J, et al.
Publicat: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
per: Tarning, J, et al.
Publicat: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
per: Zongo, I, et al.
Publicat: (2014)

Identification of an isomer impurity in piperaquine drug substance.
per: Lindegårdh, N, et al.
Publicat: (2006)

Automated solid-phase extraction method for the determination of piperaquine in whole blood by rapid liquid chromatography.
per: Lindegårdh, N, et al.
Publicat: (2003)

Automated solid-phase extraction method for the determination of piperaquine in plasma by peak compression liquid chromatography.
per: Lindegårdh, N, et al.
Publicat: (2003)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
per: Adam, I, et al.
Publicat: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
per: Adam, I, et al.
Publicat: (2012)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
per: Smithuis, F, et al.
Publicat: (2006)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
per: Rijken, M, et al.
Publicat: (2011)

Development and validation of a solid-phase extraction-liquid chromatographic method for determination of amoxicillin in plasma.
per: Lindeg?rdh, N, et al.
Publicat: (2005)

Efficacy and safety of dihydroartemisinin-piperaquine.
per: Myint, H, et al.
Publicat: (2007)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
per: Chotsiri, P, et al.
Publicat: (2017)

High throughput assay for the determination of piperaquine in plasma.
per: Lindeg?rdh, N, et al.
Publicat: (2005)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
per: Issaka Zongo, et al.
Publicat: (2014-01-01)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
per: Permala, J, et al.
Publicat: (2017)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
per: Tarning, J, et al.
Publicat: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
per: Tarning, J, et al.
Publicat: (2014)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
per: Bergstrand, M, et al.
Publicat: (2014)

High throughput assay for the determination of lumefantrine in plasma.
per: Annerberg, A, et al.
Publicat: (2005)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
per: Lwin, K, et al.
Publicat: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
per: Lwin, K, et al.
Publicat: (2012)